DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

406

Participants

Timeline

Start Date

August 27, 2012

Primary Completion Date

July 19, 2018

Study Completion Date

January 14, 2020

Conditions
Breast Cancer
Interventions
PROCEDURE

diffusion-weighted magnetic resonance imaging

diffusion-weighted magnetic resonance imaging examination and subsequent radiologist interpretation

Trial Locations (7)

19104

University of Pennsylvania, Philadelphia

35294

University of Alabama at Birmingham, Birmingham

55455

University of Minnesota, Minneapolis

77030

University of Texas M.D. Anderson Cancer Center, Houston

94143

University of California, San Francisco, San Francisco

97239

Oregon Health and Science University, Portland

98195

University of Washington/SCCA, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

American College of Radiology Imaging Network

NETWORK

NCT01564368 - DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy | Biotech Hunter | Biotech Hunter